E3X Bio, Inc. logo

E3X Bio, Inc.

E3X Bio, Inc. develops inhibitors and activators of E3 Ubiquitin (Ub) ligases for drug discovery and development for cancer and neurodegeneration.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.e3xrx.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
CA
San Francisco
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]